'indian ip and liabilities law barrier to pharma r&d investment'
.
chat with us in facebook messenger. find out what's happening in the world as it unfolds...
..
.
“it may be just out of an abundance of caution and privacy. certainly, staying a little longer may imply that this is a little bit more of a complex situation.”.
in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance..
gov. andrew cuomo announced a new lyme and other tick-borne disease control plan tuesday to keep the public informed and free of tick-borne diseases...
when bruschi suffered a stroke in 2005, he was treated at massachusetts general hospital, which he said was well equipped to handle the medical emergency..., an emerita professor in the department of food science & technology at uc davis..